No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
---|---|---|---|---|---|---|---|---|
1 | 00842768039416 | 10873440 | B4265-37 | For coagulation tests and as a rinsing solution for the sample needles of the Sy For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems | KQJ | SYSTEM, FIBRINOGEN DETERMINATION | Dade® CA System Buffer | |
2 | 00842768028441 | 10385332 | LKPM | For use in daily maintenance of the IMMULITE® and IMMULITE® 1000 systems | JJQ | COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE | 1 | IMMULITE® Probe Cleaning Kit |
3 | 00842768028427 | 10385231 | L2PWSM | For use in the routine operation of the IMMULITE® 2000 and IMMULITE® 2500 Analyzers | JJQ | COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE | IMMULITE 2000/XPi Probe Wash Module | |
4 | 00842768017872 | 10446691 | OWZG23 | Quantitative determination of fibrinogen in plasma | KQJ | SYSTEM, FIBRINOGEN DETERMINATION | Multifibren® U | |
5 | 00842768017865 | 10446689 | OWZG19 | Quantitative determination of fibrinogen in plasma | KQJ | SYSTEM, FIBRINOGEN DETERMINATION | Multifibren® U | |
6 | 00842768017087 | 10873532 | OPOD05 | For quality control of the INNOVANCE® Heparin assay | GGN | Plasma, coagulation control | INNOVANCE Heparin UF Control 2 | |
7 | 00842768016134 | 10446085 | OQIO19 | N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems | JJY | Multi-analyte controls, all kinds (assayed) | N/T Protein Control SL/M | |
8 | 00842768016110 | 10446089 | OQIP19 | N/T Protein Control SL/H is a high level, multi-analyte control for use as accur N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems | JJY | Multi-analyte controls, all kinds (assayed) | N/T Protein Control SL/H | |
9 | 00842768013065 | 10446632 | OWMG15 | Quantitative determination of thrombin/antithrombin III complex (TAT) in human plasma | JBQ | ANTITHROMBIN III QUANTITATION | 2 | Enzygnost® TAT micro |
10 | 00842768012945 | 10446620 | OWLD11 | Determination of heparin activity in plasma and for the monitoring of heparin therapy | KFF | ASSAY, HEPARIN | 2 | Berichrom® Heparin |
11 | 00842768011030 | 10446415 | OTXY13 | For the determination of the activity of coagulation factor X in human plasma by For the determination of the activity of coagulation factor X in human plasma by coagulometric methods | GJT | PLASMA, COAGULATION FACTOR DEFICIENT | Coagulation Factor X Deficient Plasma | |
12 | 00842768009976 | 10446316 | OSDF13 | For the determination of the activity of coagulation factor XI in human plasma b For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods | GJT | PLASMA, COAGULATION FACTOR DEFICIENT | Coagulation Factor XI Deficient Plasma | |
13 | 00842768009761 | 10446295 | OSAR19 | Quantitative determination of IgA in human serum and plasma on BN Systems | CFN | METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) | 2 | N Antisera to Human IgA |
14 | 00842768009747 | 10446293 | OSAR11 | Quantitative determination of IgA in human serum and plasma on BN Systems | CFN | METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) | 2 | N Antisera to Human IgA |
15 | 00842768008153 | 10446136 | OQUB21 | Cleaning solution BN II, BN ProSpec® Systems and BCS® Systems | JZW | NEPHELOMETER | Cleaner SCS | |
16 | 00842768008054 | 10446127 | OQTC11 | Quantitative determination of soluble transferrin receptor (sTfR) in human serum Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems | DDG | TRANSFERRIN, ANTIGEN, ANTISERUM, CONTROL | N Latex sTfR | |
17 | 00842768007477 | 10461887 | OQGP15 | LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants | GIR | REAGENT, RUSSEL VIPER VENOM | LA 1 Screening Reagent | |
18 | 00842768007279 | 10446043 | OQDC13 | Assayed control for RF ASL and CRP assays on Siemens Systems | JJY | Multi-analyte controls, all kinds (assayed) | N/T Rheumatology Control SL/2 | |
19 | 00842768006876 | 10445990 | OPCD03 | For use as a low level assayed control for the quantitative measurement of low m For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin | GIZ | PLASMA, CONTROL, NORMAL | Berichrom® Heparin LMW Control 1 | |
20 | 00842768006845 | 10445987 | OPCA03 | For calibration of the Berichrom Heparin assay for measurement of low molecular For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | Berichrom® Heparin LMW Calibrator | |
21 | 00842768006838 | 10445986 | OPBZ03 | For use as a high level assayed control for the quantitative measurement of unfr For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin | GGC | CONTROL, PLASMA, ABNORMAL | Berichrom® Heparin UF Control 2 | |
22 | 00842768006715 | 10445973 | OPAX03 | Quantitative determination of homocysteine in human serum and plasma on BN II an Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems | LPS | URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM | 2 | N Latex HCY |
23 | 00842768006388 | 10445924 | KC735 | CYSC CON L is an assayed intralaboratory quality control for assessment of preci CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System | JJY | Multi-analyte controls, all kinds (assayed) | DImension Vista® Cystatin C Control L (low) | |
24 | 00842768006340 | 10445920 | KC716 | PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System | JJY | Multi-analyte controls, all kinds (assayed) | DImension Vista® Protein 1 Control M (medium) | |
25 | 00842768004056 | 10445731 | B4244-10 | For use as control in citrated coagulation systems | GGC | CONTROL, PLASMA, ABNORMAL | Dade® Ci-Trol® Coagulation Control Level 1 | |
26 | 00842768006173 | 10445902 | K7054 | For the quantitative measurement of immunoglobulin E in human serum and plasma ( For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System | DGC | IGE, ANTIGEN, ANTISERUM, CONTROL | DImension Vista® Immunoglobulin E Flex® reagent cartridge | |
27 | 00842768006135 | 10445898 | K7046 | For the quantitative measurement of C-reactive protein in human serum and plasma For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System | NQD | CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL | Dimension Vista hsCRP Flex reagent cartridge | |
28 | 00842768006128 | 10445897 | K7044 | For the quantitative measurement of total homocysteine in human serum and plasma For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System | LPS | URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM | DImension Vista® Homocysteine Flex® reagent cartridge | |
29 | 00842768003967 | 10445722 | B4233-60 | The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma | DAP | FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL | 2 | Dade® DIMERTEST® Latex Assay |
30 | 00842768003929 | 10445718 | B4233-15SY | Quantitative determination of fibrinogen in human plasma | GFK | FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS | 2 | Dade® Fibrinogen Determination Reagents |
31 | 00842768003905 | 10445716 | B4224-60 | Control in heparin assay procedures | KFF | ASSAY, HEPARIN | Dade® Ci-Trol® Heparin Control, High | |
32 | 00842768003899 | 10445715 | B4224-50 | Control in heparin assay procedures | KFF | ASSAY, HEPARIN | Dade® Ci-Trol® Heparin Control, Low | |
33 | 00630414992617 | 10459382 | B4132-1A | For differential staining in hematology that gives results similar to a Wright-G For differential staining in hematology that gives results similar to a Wright-Giemsa stain | KQC | STAINS, HEMATOLOGY | 1 | Diff-Quik™ Stain Set |
34 | 00630414285054 | 10873691 | OWTI15 | Quantitative determination of ADNase B in human serum on BN Systems | GTR | ANTIDEOXYRIBONUCLEASE, STREPTOCOCCUS SPP. | 1 | N Latex ADNase B (USA) |
35 | 00630414284996 | 10873685 | OQDC17 | Assayed control for RF, ASL and CRP assays on BN Systems | JJY | Multi-analyte controls, all kinds (assayed) | 1 | N/T Rheumatology Control SL/2 |
36 | 00630414237503 | 10873663 | OPJF05 | Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. | JJY | Multi-analyte controls, all kinds (assayed) | N FLC CONTROL SL2 | |
37 | 00630414237480 | 10873661 | OPJE05 | Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. | JJY | Multi-analyte controls, all kinds (assayed) | N FLC CONTROL SL1 | |
38 | 00630414023526 | 10873571 | B4233-17SY | Quantitative determination of fibrinogen in human plasma | GFK | FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS | 2 | Dade® Fibrinogen Determination Reagents |
39 | 00630414002736 | 10465217 | OVLI012 | The BN ProSpec® is a system for the quantitative determination of proteins in se The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF | JZW | NEPHELOMETER | 1 | BN ProSpec® System |
40 | 00842768028410 | 10385393 | LPWS2 | For use in the routine operation of the IMMULITE® and IMMULITE® 1000 Analyzers | JJQ | COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE | IMMULITE® Probe Wash Module | |
41 | 00842768018534 | 10445997 | OPCS05 | Quantitative determination of carbohydrate-deficient transferrin (CDT) in human Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems | NAO | Test,carbohydrate deficient transferrin | 1 | N Latex CDT Kit |
42 | 00842768014222 | 10446232 | ORHO37 | Supplementary Reagent for coagulation tests | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | Calcium Chloride Solution | |
43 | 00842768013478 | 10446673 | OWWR17 | Determination of the functional activity of antithrombin III (AT III) in human plasma | JPE | ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY | 2 | Berichrom® Antithrombin III (A) |
44 | 00842768013461 | 10446672 | OWWR15 | Determination of the functional activity of antithrombin III (AT III) in human plasma | JPE | ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY | 2 | Berichrom® Antithrombin III (A) |
45 | 00842768012778 | 10446604 | OWHU21 | Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum | DCN | SYSTEM, TEST, C-REACTIVE PROTEIN | 2 | RapiTex® CRP |
46 | 00842768012686 | 10446595 | OWHG13 | Quantitative determination of Ig light chains, type kappa in human serum on BN Systems | DFH | KAPPA, ANTIGEN, ANTISERUM, CONTROL | 2 | N Antiserum to Human-Ig/L-chain, K-type |
47 | 00842768012297 | 10446534 | OVLC21 | The N Evaporation Cap 2.5ml is part of the BN ProSpec system. | JZW | NEPHELOMETER | N Evaporation Caps for Control Vials (2.5 mL) | |
48 | 00842768012174 | 10446521 | OVIC11 | The N Predilution Well is used for settings of dilutions of standards, controls and sera. | DEW | IGG, ANTIGEN, ANTISERUM, CONTROL | N Predilution Wells | |
49 | 00842768011443 | 10446458 | OUMU15 | Supplementary reagent for multiple protein assays on Siemens systems | CFN | METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) | 2 | N Supplementary Reagent/Precipitation |
50 | 00842768011085 | 10446420 | OUAX41 | Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum | DCN | SYSTEM, TEST, C-REACTIVE PROTEIN | 2 | RapiTex® CRP |
No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
---|---|---|---|---|---|---|
1 | 03607450006780 | 00678 | STA® - System Control N + P | DIAGNOSTICA STAGO | ||
2 | 03607450006766 | 00676 | STA® - Coag Control N + ABN | DIAGNOSTICA STAGO | ||
3 | 03607450002010 | 00201 | STA® - Control LA 1 + 2 | DIAGNOSTICA STAGO | ||
4 | 00855360006250 | 702-001 | 702-001 | REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulatio REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulation studies for In Vitro Diagnostic Use.PRINCIPLE OF THE PROCEDURECoagulation Control 2 is tested in the same manner as citrated patient plasma samples to assess the performance of each assay run, for the parameters. Testing variables in each laboratory, including equipment, reagents, and technique may influence control recovery. Although an expected range is provided for each parameter, laboratories should establish their own expected range for their particular instrument-reagent system. Refer to Package Insert. | REAADS Coagulation Control 2 | CORGENIX MEDICAL CORPORATION |
5 | 00850201006130 | 816A | 816A | LAtrol ABNORMAL CONTROL PLASMA | BIOMEDICA ADI INC. | |
6 | 00845275000573 | 100597 | Thermo Scientific Pacific Hemostasis® | FISHER DIAGNOSTICS | ||
7 | 00845275000566 | 100596 | Thermo Scientific Pacific Hemostasis® | FISHER DIAGNOSTICS | ||
8 | 00843876000176 | CCWLP-10 | CRYOcheck™ Weak Lupus Positive Control | PRECISION BIOLOGIC INC | ||
9 | 00843876000169 | CCWLP-05 | CRYOcheck™ Weak Lupus Positive Control | PRECISION BIOLOGIC INC | ||
10 | 00843876000152 | CCLP-10 | CRYOcheck™ Lupus Positive Control | PRECISION BIOLOGIC INC | ||
11 | 00843876000145 | CCLP-05 | CRYOcheck™ Lupus Positive Control | PRECISION BIOLOGIC INC | ||
12 | 00843876000114 | CCA2-10 | 00843876010113 | CRYOcheck™ Abnormal 2 Control | PRECISION BIOLOGIC INC | |
13 | 00843876000107 | CCA1-10 | CRYOcheck™ Abnormal 1 Control | PRECISION BIOLOGIC INC | ||
14 | 00843876000091 | ARP2-10 | CRYOcheck™ Abnormal 2 Reference Control | PRECISION BIOLOGIC INC | ||
15 | 00843876000084 | ARP1-10 | CRYOcheck™ Abnormal 1 Reference Control | PRECISION BIOLOGIC INC | ||
16 | 00843876000077 | ARP1-05 | CRYOcheck™ Abnormal 1 Reference Control | PRECISION BIOLOGIC INC | ||
17 | 00842768011580 | 10446472 | OUPZ19 | Assayed control used to monitor the performance of coagulation assays in the pat Assayed control used to monitor the performance of coagulation assays in the pathological range | Control Plasma P | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
18 | 00842768008368 | 10446154 | OQWE11 | LA Control Low is a low positive control plasma for use in Lupus Anticoagulant c LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers | LA Control Low | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
19 | 00842768008351 | 10446153 | OQWD11 | LA Control High is a high positive control plasma for use in Lupus Anticoagulant LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers | LA Control High | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
20 | 00842768006852 | 10445988 | OPCB03 | For use as a high level assayed control for the quantitative measurement of low For use as a high level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin | Berichrom® Heparin LMW Control 2 | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
21 | 00842768006838 | 10445986 | OPBZ03 | For use as a high level assayed control for the quantitative measurement of unfr For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin | Berichrom® Heparin UF Control 2 | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
22 | 00842768004056 | 10445731 | B4244-10 | For use as control in citrated coagulation systems | Dade® Ci-Trol® Coagulation Control Level 1 | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
23 | 00817869020243 | SC-113 | SC-113 | Animal Plasma Control Level II | ANALYTICAL CONTROL SYSTEMS INC | |
24 | 00816426020894 | K81C-6M | K81C-6M | For use as a consistent test sample of known concentration for monitoring assay For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents. | K-ASSAY® Plasma Control | KAMIYA BIOMEDICAL COMPANY, LLC |
25 | 00815696021150 | 1300-250.0 | George King Factor XIII Deficient plasma is fresh frozen human plasma derived fr George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor. | George King Factor XIII Deficient Plasma | GEORGE KING BIO-MEDICAL, INC | |
26 | 00815696021143 | 5000-250.0 | George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma d George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS). | George King Positive Lupus Anticoagulant | GEORGE KING BIO-MEDICAL, INC | |
27 | 00815696021112 | 5000 - 100 mL | George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS). | George King Positive Lupus Anticoagulant | GEORGE KING BIO-MEDICAL, INC | |
28 | 00815696021068 | 0085-20 | George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit) | George King AbCOR Convenience Kit | GEORGE KING BIO-MEDICAL, INC | |
29 | 00815696021051 | 0085-10 | George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit) | George King AbCOR Convenience Kit | GEORGE KING BIO-MEDICAL, INC | |
30 | 00815696020986 | 1300-100.0 | George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor. | George King Factor XIII Deficient Plasma | GEORGE KING BIO-MEDICAL, INC | |
31 | 00815696020979 | 1402 - 1.5 | George King von Willebrand, Type 2B, is citrated human fresh frozen plasma deriv George King von Willebrand, Type 2B, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand aG in citrated plasma. | George King von Willebrand plasma, Type 2B | GEORGE KING BIO-MEDICAL, INC | |
32 | 00815696020962 | 1401 - 1.5 | George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma, Type 1 | GEORGE KING BIO-MEDICAL, INC | |
33 | 00815696020955 | 1300-bulk | George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor. | George King Factor XIII Deficient Plasma | GEORGE KING BIO-MEDICAL, INC | |
34 | 00815696020900 | 1404 - 200.0 | George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma, Type 2A | GEORGE KING BIO-MEDICAL, INC | |
35 | 00815696020894 | 1404 - 1.5 | George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma, Type 2A | GEORGE KING BIO-MEDICAL, INC | |
36 | 00815696020887 | 1404 - 1.0 | George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen pla George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma, Type 2A | GEORGE KING BIO-MEDICAL, INC | |
37 | 00815696020870 | 1403-200.0 | George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma. | George King von Willebrand Plasma, Type 3 | GEORGE KING BIO-MEDICAL, INC | |
38 | 00815696020863 | 1402-200.0 | George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen pla George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma | George King von Willebrand Plasma, Type 2B | GEORGE KING BIO-MEDICAL, INC | |
39 | 00815696020856 | 1401-200.0 | George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma. | George King von Willebrand Plasma | GEORGE KING BIO-MEDICAL, INC | |
40 | 00815696020849 | 5000 - bulk | George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS). | George King Positive Lupus Anticoagulant | GEORGE KING BIO-MEDICAL, INC | |
41 | 00815696020740 | 1403 - 1.5 | George King von Willebrand plasma, Type 3 is citrated human fresh frozen plasma George King von Willebrand plasma, Type 3 is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma - Type 3 | GEORGE KING BIO-MEDICAL, INC | |
42 | 00815696020733 | 1800-1.5 | George King Factor VIII Deficient plasma with Inhibitor is fresh frozen citrated George King Factor VIII Deficient plasma with Inhibitor is fresh frozen citrated human plasma derived from a congenital Factor VIII deficient donor who has developed an antibody to FVIII. | George King Factor VIII Deficient Plasma with Inhibitor | GEORGE KING BIO-MEDICAL, INC | |
43 | 00815696020726 | 1700-1.5 | George King Prekallikrein Deficient plasma is fresh frozen citrated human plasma George King Prekallikrein Deficient plasma is fresh frozen citrated human plasma derived from congenital Prekallikrein Deficient donors. | George King Prekallikrein Deficient Plasma | GEORGE KING BIO-MEDICAL, INC | |
44 | 00815696020658 | 1403-1.0 | George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasm George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand in citrated plasma. | George King von Willebrand Plasma Type 3 | GEORGE KING BIO-MEDICAL, INC | |
45 | 00815696020641 | 1402-1.0 | George King von Willebrand plasma, Type 2B, is citrated fresh frozen human plas George King von Willebrand plasma, Type 2B, is citrated fresh frozen human plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma Type 2B | GEORGE KING BIO-MEDICAL, INC | |
46 | 00815696020634 | 1401-1.0 | George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma. | George King von Willebrand Plasma Type 1 | GEORGE KING BIO-MEDICAL, INC | |
47 | 00815696020627 | 1800-1.0 | George King Factor VIII Deficient plasma with Inhibitor is fresh frozen citrated George King Factor VIII Deficient plasma with Inhibitor is fresh frozen citrated human plasma derived from a congenital Factor VIII deficient donor who has developed an antibody to FVIII. | George King Factor VIII Deficient Plasma with Inhibitor | GEORGE KING BIO-MEDICAL, INC | |
48 | 00815696020498 | 0065-35 | SysCOR Plus is a System Control convenience kit which contains different levels SysCOR Plus is a System Control convenience kit which contains different levels of control material that can be used to correlate results when changing lot numbers of reagents and/or instrument platforms. Similar to the SysCOR kit but with five additional Coumadin® control plasmas. | George King SysCOR Plus Kit | GEORGE KING BIO-MEDICAL, INC | |
49 | 00815696020481 | 0065-30 | SysCOR is a System Control convenience kit which contains different levels of co SysCOR is a System Control convenience kit which contains different levels of control material that can be used to correlate results when changing lot numbers of reagents and/or instrument platforms. | George King SysCOR Kit | GEORGE KING BIO-MEDICAL, INC | |
50 | 00815696020474 | 0014-10 | The AMR von Willebrand Kit is a convenience kit that contains five levels of cit The AMR von Willebrand Kit is a convenience kit that contains five levels of citrated human fresh frozen control material that can be used to verify the analytical measurement range of vWF Ag. | George King AMR von Willebrand Kit | GEORGE KING BIO-MEDICAL, INC |